
Glyn Edwards MBE
individual
About
Glyn Edwards MBE is a UK biotechnology executive and board director best known for serving as CEO of Summit Therapeutics from April 2012, where he led the company through its NASDAQ listing and focused it on infectious and rare disease programs. Earlier, he was interim CEO of the BioIndustry Association and CEO of Antisoma plc, and he previously held business-development leadership at Therapeutic Antibodies Ltd. More recently, he has held board roles at OrthoSon and MitoRx Therapeutics.
Areas of interest
biotechrare diseaseinfectious diseaseoncologymedtechdegenerative diseasemitochondrial therapeutics